- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06253858
Ultrasound (US) Guided External Ventricular Catheter Placement
June 4, 2026 updated by: Chris Zacko, Milton S. Hershey Medical Center
To assess the accuracy the SOLOPASS® System US based in the placement of external ventricular drain into the cranial cavity.
This study will aim at evaluating the proposed efficacy of the device in targeting the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Sara Craig, MNR, BS
- Phone Number: 285799 717-531-0003
- Email: scraig2@pennstatehealth.psu.edu
Study Locations
-
-
Pennsylvania
-
Hershey, Pennsylvania, United States, 17033
- Recruiting
- Penn State Health Milton S. Hershey Medical Center
-
Contact:
- Sara Craig Clinical Research Coordinator, BS, MNR
- Phone Number: 285799 717-531-0003
- Email: Scraig2@pennstatehealth.psu.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Decision made to perform the procedure by the primary consultant
- Age 18 or older
- Neuro ICU stay
- Newly diagnosed hydrocephalus
- Has a recent CT within the past 24 hrs
- Normal platelets and coagulation profile
- No active infection or currently on antibiotics
- The targeted fluid compartment has more than 50 percent CSF vs blood by CT scan imaging
Exclusion Criteria:
- Age <18
- Not in Neuro ICU setting
- Previous placement of a ventricular catheter
- More than 50 percent of the fluid compartment is filled with blood by CT scan
- Time to include in the trial prohibited by clinical personnel
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Catheter placement with Solopass system
The Solopass US system will be used during catheter placement procedure to guide the placement of the catheter.
|
This device is used as a guidance for placing a brain catheter to target the brain ventricles and decrease multiple brain passes, incorrect deployment and malfunctioning of the drain.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Average number of passes needed to place the catheter in each subject.
Time Frame: 0 minutes
|
Measured by the number of passes needed to place the catheter.
If the first attempt fails, another US sweep will be performed, and another attempt will be performed.
If that fails, then the procedure will be aborted.
|
0 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Post procedure imaging accuracy of the placement of the EVD will be performed by reviewing post procedure imaging using the Kakarla scoring system
Time Frame: up to 7 days
|
Grade 1 means optimal placement in the ipsilateral frontal horn or third ventricle; Grade 2 means a functional placement in the contralateral lateral ventricle or no eloquent cortex; and Grade 3 means suboptimal placement in the eloquent cortex or nontarget cerebrospinal fluid space, with or without functional drainage
|
up to 7 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Length of time of the procedure
Time Frame: Up to three hours
|
Number of minutes necessary to complete the procedure placement of the catheter
|
Up to three hours
|
|
Number of revision
Time Frame: up to 7 days
|
Quantity of revisions due to the catheter malfunction
|
up to 7 days
|
|
Number of subjects with Cerebrospinal fluid (CSF) infection
Time Frame: up to 7 days
|
CSF will be collected as part of standard of care after the procedure and tested for infection.
|
up to 7 days
|
|
Number of subjects with Superficial surgical site infection (SSI)
Time Frame: up to 7 days
|
(The CDC defines SSI as deep and superficial.
A superficial incisional SSI is an infection in the area of the skin where the incision was made.
A deep incisional SSI occurs beneath the incision area in the muscle and the tissues surrounding the muscles.
Signs to be monitored daily and put in a checklist will include redness, pain, unexplained fever source, pain, warmth, pus or swelling.)
|
up to 7 days
|
|
Longevity of the device function
Time Frame: up to 7 days
|
Number of days until a subsequent catheter is placed
|
up to 7 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: J C Zacko, MD, Milton S. Hershey Medical Center
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2026
Primary Completion (Estimated)
December 1, 2026
Study Completion (Estimated)
December 1, 2026
Study Registration Dates
First Submitted
January 22, 2024
First Submitted That Met QC Criteria
February 2, 2024
First Posted (Actual)
February 12, 2024
Study Record Updates
Last Update Posted (Actual)
June 5, 2026
Last Update Submitted That Met QC Criteria
June 4, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STUDY00022095
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.